Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitReceivables - NetRevenue (Gross)Shares Outstanding
Ratios

BioRestorative Therapies (BRTX) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for BioRestorative Therapies (BRTX) over the last 7 years, with Q3 2025 value amounting to $10570.0.

  • BioRestorative Therapies' Cost of Revenue fell 4206.0% to $10570.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $25547.0, marking a year-over-year increase of 329.11%. This contributed to the annual value of $28072.0 for FY2024, which is N/A changed from last year.
  • Per BioRestorative Therapies' latest filing, its Cost of Revenue stood at $10570.0 for Q3 2025, which was down 4206.0% from $8729.0 recorded in Q2 2025.
  • Over the past 5 years, BioRestorative Therapies' Cost of Revenue peaked at $18243.0 during Q3 2024, and registered a low of $2909.0 during Q1 2025.